Susquehanna International Group, LLP Pacira Bio Sciences, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $532,350 - $1.29 Million	-45,500 Reduced 34.44%	86,600 $1.3 Million
Q2 2024 Aug 15, 2024	BUY	$25.5 - $31.51 $2.39 Million - $2.96 Million	93,900 Added 245.81%	132,100 $3.78 Million
Q1 2024 May 07, 2024	BUY	$27.7 - $35.48 $24,930 - $31,931	900 Added 2.41%	38,200 $1.12 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $615,888 - $802,854	-23,400 Reduced 38.55%	37,300 $1.26 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $1.38 Million - $1.81 Million	-45,100 Reduced 42.63%	60,700 $1.86 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $1.61 Million - $2.12 Million	44,700 Added 73.16%	105,800 $4.24 Million
Q1 2023 May 16, 2023	BUY	$35.53 - $43.38 $2.17 Million - $2.65 Million	61,100 New	61,100 $2.49 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $830,088 - $954,018	16,200 Added 261.29%	22,400 $1.19 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.